Yash Bhatnagar is an Associate on the Investments team at Roivant Sciences. At Roivant, Mr. Bhatnagar focuses on the diligence of development-stage therapeutic candidates as well as the launch of new ventures. Prior to joining Roivant, Mr. Bhatnagar worked as a Junior Analyst at Balyasny Asset Management and as an Investment Banking Analyst on the Healthcare team at Wells Fargo Securities.
Mr. Bhatnagar received a B.S.E. in Biomedical Engineering from Duke University, where he was a three-year member of the Men’s Rowing Team.
¡Hagamos correr la voz sobre la inmunoterapia! Haga clic para compartir esta página con su comunidad.